Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

The results of pollicization for congenital thumb hypoplasia.

Tonkin MA, Boyce DE, Fleming PP, Filan SL, Vigna N.

J Hand Surg Eur Vol. 2015 Jul;40(6):620-4. doi: 10.1177/1753193414535177. Epub 2014 May 23.

PMID:
24859992
2.

A randomized, placebo-controlled, multicenter study of divalproex sodium extended-release in the acute treatment of mania.

Hirschfeld RM, Bowden CL, Vigna NV, Wozniak P, Collins M.

J Clin Psychiatry. 2010 Apr;71(4):426-32. doi: 10.4088/JCP.08m04960yel. Epub 2010 Mar 9.

PMID:
20361904
3.

Divalproex sodium in children with partial seizures: 12-month safety study.

Lenz RA, Elterman RD, Robieson WZ, Vigna NV, Saltarelli MD.

Pediatr Neurol. 2009 Aug;41(2):101-10. doi: 10.1016/j.pediatrneurol.2009.03.005.

PMID:
19589457
4.

A double-blind, randomized, placebo-controlled trial of divalproex extended-release in the treatment of bipolar disorder in children and adolescents.

Wagner KD, Redden L, Kowatch RA, Wilens TE, Segal S, Chang K, Wozniak P, Vigna NV, Abi-Saab W, Saltarelli M.

J Am Acad Child Adolesc Psychiatry. 2009 May;48(5):519-532. doi: 10.1097/CHI.0b013e31819c55ec.

PMID:
19325497
5.

Long-term safety of divalproex sodium extended-release in children and adolescents with bipolar I disorder.

Redden L, DelBello M, Wagner KD, Wilens TE, Malhotra S, Wozniak P, Vigna NV, Greco N 4th, Kovacs X, Abi-Saab W, Saltarelli M; Depakote ER Pediatric Mania Group.

J Child Adolesc Psychopharmacol. 2009 Feb;19(1):83-9. doi: 10.1089/cap.2008.0106.

PMID:
19232026
6.

Mutational analysis of the interacting cell death regulators CED-9 and CED-4.

Ottilie S, Wang Y, Banks S, Chang J, Vigna NJ, Weeks S, Armstrong RC, Fritz LC, Oltersdorf T.

Cell Death Differ. 1997 Oct;4(7):526-33.

7.

IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs.

Tamm I, Wang Y, Sausville E, Scudiero DA, Vigna N, Oltersdorf T, Reed JC.

Cancer Res. 1998 Dec 1;58(23):5315-20.

Supplemental Content

Support Center